Voyager Therapeutics Inc. (NASDAQ:VYGR) Stock Moves Up After Positive Preclinical Data
VoyagerTherapeutics Inc. (NASDAQ: VYGR) was up 4% on Friday after the company announced the presentation of preclinical data showing that intravenous dosing of the novel AAV vectorized antibody by the TRACER screening tech, incorporating anti-HER2 antibody payload, can prevent the growth of tumor in HER2+ brain metastases models. Key findings of the study will be presented by Dan R. Laks, voyager Scientist II. Trading Data On Friday, VYGR stock went…